Health ❯Pharmacology ❯Diabetes Medications
AgRP Neuron Inhibition
New research highlights hyperactive hypothalamic AgRP neurons as a key driver of diabetes, reframing the disease as a neurocircuitry disorder and opening pathways for brain-targeted therapies.